Australian (ASX) Stock Market Forum

IMM - Immutep Limited

Jump to new
pixel said:
Hi Charlie;
the listing won't happen at a set price as if it were an IPO. Instead, it will start at the equivalent of 30 shares at about 20 Aussie cents; say US$6.50 would be my guess.
As to the timing, I may be wrong, but if they begin trading on Monday, it won't be after our ASX session has closed. And that could indeed leave lots of room for speculation here. ... in either direction ...
Click to expand...

Pixel,

They have not stated a start date for the listing yet. This is exactly why buying must happen now. There is no doubt what direction, only up. Check back here on Monday for proof.
 
Can anyone please explain how a listing on the NASDAQ affects share prices for Australian shares?

I've never seen a company do this..
 
Chasero said:
Can anyone please explain how a listing on the NASDAQ affects share prices for Australian shares?

I've never seen a company do this..
Click to expand...

it shouldn't, it just give the company exposure to US market for more investors and capital... there are a few company dual list at home and oversea.
 
ROE said:
it shouldn't, it just give the company exposure to US market for more investors and capital... there are a few company dual list at home and oversea.
Click to expand...

Ah i see..

Anyways +20% last 2 days is pretty good. Will be interesting if this rally continues monday..
 
:D

Prima BioMed announced that it has received a manufacturing license from the Therapeutic Goods Administration (TGA) to produce the CVac immunotherapy ovarian cancer vaccine in Australia. The license is a key component in the company's development timeline to initiate the pivotal CANVAS clinical trial and another important step towards commercialisation of the CVac vaccine into pharmacy oncology markets globally. The TGA manufacturing license will allow the company to manufacture the CVac vaccine for clinical trial use where it will be used to treat ovarian cancer patients under the major CANVAS (CANcer VAccine Study); a multinational, multi-centre, randomised, double-blinded, placebo-controlled trial of CVac in Australia
 
RADV said:
:D

Prima BioMed announced that it has received a manufacturing license from the Therapeutic Goods Administration (TGA) to produce the CVac immunotherapy ovarian cancer vaccine in Australia. The license is a key component in the company's development timeline to initiate the pivotal CANVAS clinical trial and another important step towards commercialisation of the CVac vaccine into pharmacy oncology markets globally. The TGA manufacturing license will allow the company to manufacture the CVac vaccine for clinical trial use where it will be used to treat ovarian cancer patients under the major CANVAS (CANcer VAccine Study); a multinational, multi-centre, randomised, double-blinded, placebo-controlled trial of CVac in Australia
Click to expand...

Thanks RADV,

I saw this today and was surprised the sp didn't go higher. I have been in and out of this recently for a nice profit.

gg
 
lucifuge said:
PRR will list on NASDAQ on April 16th 2012

http://imagesignal.comsec.com.au/docserver/01287174.pdf?fileid=01287174&datedir=20120413&edt=MjAxMi0wNC0xMysxNDoyODo1MSsxMjArMCtjb21zZWMrcmVkaXJlY3QrL2ltYWdlc2lnbmFsL2Vycm9ycGFnZXMvUERGVGltZW91dC5odG1sKy9pbWFnZXNpZ25hbC9lcnJvcnBhZ2VzL3BkZmRlbGF5ZWQuanNw
Click to expand...

Got a small position at 25c. The US tend to be a bit more generous when it comes to valuing biotechs.

The Chart isn't looking too bad with prices breaking out of a 2 month consolidation zone. The resistance at 28 (which sent prices back last time) still needs to be overcome. My guess is that it will get there on Monday ASX trading hours... and whether it pushes through will depend on the actual opening Monday night in the States.

20120413 PRR.PNG

If it goes above 28c then 36c might be the a target based on the 12c range in the most recent upleg.
 
Got in today at 0.26.

Kept getting dumped into then wam.. it went again.

I just followed this because I haven't seen a stock go above 90 posts on HC in a long time lol

*In with the herd*
 
lucifuge said:
PRR will list on NASDAQ on April 16th 2012
Click to expand...

So it listed and flopped?

PRR back to 22.5c. Might rebound tomorrow.. doesn't make much sense since it was 22.5c and the patent gave it a 22% boost. Oversold imo - all the traders expected it to rise or something.

Anyway gl all holders.
 
Chasero said:
So it listed and flopped?

PRR back to 22.5c. Might rebound tomorrow.. doesn't make much sense since it was 22.5c and the patent gave it a 22% boost. Oversold imo - all the traders expected it to rise or something.

Anyway gl all holders.
Click to expand...

It hardly had any volume and traded at a slight premium to the listing here. $US 8.30 close = $A 0.265. But with such little volume we are probably going to be leading there.

I sold half at 27.5c before listing and then the remainder at 25c on Tuesday. A nothing trade really.

It's not impossible for 28c to be challenged again, but prices better don't go much lower.
 
skc said:
It hardly had any volume and traded at a slight premium to the listing here. $US 8.30 close = $A 0.265. But with such little volume we are probably going to be leading there.

I sold half at 27.5c before listing and then the remainder at 25c on Tuesday. A nothing trade really.

It's not impossible for 28c to be challenged again, but prices better don't go much lower.
Click to expand...

Hopefully uptrend is not breached.

22.5c should hold tomorrow. It is also close to the 200 day moving avg so that entry should provide support.
 
Hopefully bottom was in yesterday at 19.5c.

That's quite a big tumble from 28c highs when all expectations were dampened by a report/nasdaq listing.

Needs to close at 20.5c today
 
I nearly bought in at 18c now down to 15c! Anyone know what is going on here - surely a change to the Board wouldn't lead to this....lol
 
Hi All


Did anyone watch the webcast from the shareholder briefing held the other week, or maybe even attended it in person?

Personally it didn't fill me with confidence really. What I found interesting was that one of the questions asked, was how PRR wouldn't file a complaint in regards to an investor report, made by some journalist straight after the NASDAQ listing, and that said report was a reason for the sharp drop from the NASDAQ highs?

Any thoughts? Has anyone got a link to this report?

I guess my feeling of unease is in regards to how I thought they came across as slightly nervous in my view and with no new information really, apart from what's been recently announced.

/D
 
Danneman said:
Hi All


Did anyone watch the webcast from the shareholder briefing held the other week, or maybe even attended it in person?

Personally it didn't fill me with confidence really. What I found interesting was that one of the questions asked, was how PRR wouldn't file a complaint in regards to an investor report, made by some journalist straight after the NASDAQ listing, and that said report was a reason for the sharp drop from the NASDAQ highs?

Any thoughts? Has anyone got a link to this report?

I guess my feeling of unease is in regards to how I thought they came across as slightly nervous in my view and with no new information really, apart from what's been recently announced.

/D
Click to expand...

A "challenging stock " The simple answer is who knows?" From the charting view it is basket, in a downtrend.

I would avoid atm.

gg
 
Top